Skip to primary navigation Skip to main content
Buffalo Local Index
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Local Stocks
Gilead Sciences (NQ: GILD)
68.17 USD  +0.34 (+0.50%)
Official Closing Price  /  Updated: 8:00 PM EDT, May 23, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 5,093,159
Open 67.36
Bid (Size) 68.03 (800)
Ask (Size) 68.17 (300)
Prev. Close 67.83
Today's Range 67.35 - 68.38
52wk Range 63.76 - 89.54
Shares Outstanding 1,300,260,832
Dividend Yield 3.20%
Performance
YTD
-8.00%
-8.00%
1 Month
-7.89%
-7.89%
3 Month
-15.52%
-15.52%
6 Month
-6.39%
-6.39%
1 Year
+5.38%
+5.38%
Top News
More News
Recent Developments in the Stem Cell Market
FinancialBuzz.com News Commentary Read More
from PR Newswire
The FDA Is Trying To 'Shame' Celgene, Gilead — Here's Why It Won't Work
Celgene toppled to a four-year low Thursday after it appeared on a list from the FDA attempting to "shame" drugmakers working to block generic competition. Read More
from Investor's Business Daily
More News
Read More
U.S. Food and Drug Administration Approves Expanded Indication for Truvada® (Emtricitabine and Tenofovir Disoproxil Fumarate) for Reducing the Risk of Acquiring HIV-1 in Adolescents
from Business Wire News Releases
Why These Biotech Stocks Could Spike In The Second Half Of 2018
from Investor's Business Daily
We Did The Math MGV Can Go To $86
category ETFs
from ETF Channel
UPDATE 1-Regulators flag possible birth defect link to GSK's HIV drug
category companyNews
from Reuters: Company News
Kite Announces New Worldwide Facilities and Expanded Collaboration With National Cancer Institute to Support Cell Therapy Pipeline
from Business Wire News Releases
EU warns of possible birth defect link to GSK's HIV drug
category companyNews
from Reuters: Company News
Alpine Immune Sciences Provides Corporate Update and Reports First Quarter 2018 Financial Results
from Business Wire News Releases
Breakout Watch: Biotech Stock With 172% Growth Enters Buy Zone
from Investor's Business Daily
UPDATE 4-FDA names drugmakers potentially acting to delay cheap generics
category companyNews
from Reuters: Company News
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial